Progenity Announces Successful Transfer of Liquid Biopsy Technologies
Progenity, Inc. Enumera Molecular Formed to Develop and Commercialize Next-Generation Solutions for Liquid Biopsy SAN DIEGO, May 05, 2022 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG) today ann...